Just Other Articles

With the growing uncertainty in the electricity and natural gas prices, and increased awareness of

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

energy conservation, many facilities managers of UK companies are exploring every option to reduce

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

heir costs and decrease their impact on the environment.

Until very recently, when it came to ener

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

gy usage, the primary concern of facilities managers was to solely concentrate on securing the lowe

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

t rates for their electricity and gas. But now they are finding growing pressure from upper manag

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ement to lower costs via conservation and to be more “green” with their decisions.

“In the past ev

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ryone just wanted to know who had the cheapest tariffs,” explained Rebecca Smith, Director at Direc

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

t Power Associates Ltd. in the United Kingdom. “But now we are getting more and more questions abo

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

t green energy. Green energy prices are comparable to that of normal “brown” energy, while giving

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

a company a piece of mind that they are having less of a negative impact on the environment. In ad

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ition, it reflects positively in the publics’ eye, and this is just the sort of image companies fee

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

they need to portray.”

Energy conservation in another buzz word often heard throughout the market

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

. In response to the growing threat of climate change, the UK government set up a program to help

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

businesses reduce their carbon emissions. “This is real simple one, I’m not sure why more people d

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

on’t take advantage of this,” commented Smith. “If your company qualifies, you can receive governm

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

nt funding for energy conservation projects.” Many recommendations do not require capital to imple

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ment, and there is a typical 20%-30% site savings potential identified in energy costs and usage.

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

K businesses will always be most concerned with the bottom line and keeping costs at a minimum. B

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ut with increased chatter regarding climate change and energy conservation, facilities managers are

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

faced with changing their thinking when securing their energy contracts and planning for the future

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/44241/justotherarticles-UK-Facilities-Managers-Focusing-on-Conservation.html">UK Facilities Managers Focusing on Conservation</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/44241/justotherarticles-UK-Facilities-Managers-Focusing-on-Conservation.html]UK Facilities Managers Focusing on Conservation[/url]

Exchange is a program that allows the owner of a certain property that is used for investment to be exchanged with another property and defer paying the taxes.

Sometimes a medical billing company has to battle itself to get anything done. What follows is a true story of a company at war with itself.

Tags

Links

Just Other Articles - UK Facilities Managers Focusing on Conservation

Related Articles: